Evaxion Biotech AS (EVAX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.25
• Market Cap: $28.11M
• EPS: $-4.00
• 52-Week High: $12.15
• 52-Week Low: $1.20

About Evaxion Biotech AS

Evaxion Biotech AS (EVAX) is a pioneering clinical-stage biopharmaceutical company based in Hørsholm, Denmark, leveraging advanced artificial intelligence to drive innovation in immunotherapy. With a strategic focus on addressing unmet medical needs in oncology, bacterial diseases, and viral infections, the company utilizes its proprietary platform to identify and develop novel therapeutic candidates. As Evaxion progresses its diverse pipeline, it aims to transform treatment paradigms and enh...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Evaxion Biotech AS and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EVAX pay dividends?

Evaxion Biotech AS (EVAX) does not currently pay a regular dividend.

What is EVAX's market cap?

Evaxion Biotech AS (EVAX) has a market capitalization of $28.11M with a current stock price of $3.25.